Q4 2016 Holdings
Filed 2017-02-14 | 31 holdings | $51.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-02-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $19.7M | 975,700 | 38.4% |
| Ardelyx Inc(ARDX)A | COM | 039697107 | $18.6M | 1,310,023 | 36.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.2M | 414,000 | 21.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $972.0K | 23,300 | 1.9% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $667.0K | 54,879 | 1.3% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $43.7K | 2,855,515 | 0.1% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $36.0K | 561,341 | 0.1% |
| Assembly Biosciences Inc | COM | 045396108 | $35.8K | 2,943,164 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $19.8K | 162,200 | 0.0% |
| Theravance Biopharma Inc | NOTE | 88339KAA0 | $19.3K | $17,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $15.4K | 2,611,906 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $15.0K | 298,712 | 0.0% |
| Fibrogen Inc.(FGENEUR)A | COM | 31572Q808 | $14.7K | 686,184 | 0.0% |
| Allergan PLCCall | COM | G0177J908 | $10.5K | 50,000 | 0.0% |
| Editas Medicine Inc COM(EDIT) | COM | 28106W103 | $10.2K | 626,762 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $9.9K | 375,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $6.5K | 1,415,687 | 0.0% |
| Fate Therapeutics Inc | COM | 311900954 | $6.4K | 2,537,026 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $3.1K | 215,812 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $2.5K | 874,447 | 0.0% |
| Kindred Biosciences Inc | COM | 494577109 | $2.4K | 571,126 | 0.0% |
| Atyr Pharma Inc(LIFEUSD) | COM | 002120103 | $2.1K | 976,986 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.0K | 273,862 | 0.0% |
| Egalet Corp | COM | 28226B104 | $1.7K | 222,300 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $1.6K | 264,773 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $1.3K | 43,200 | 0.0% |
| Chemocentryx Inc | COM | 01683L106 | $873 | 118,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $773 | 63,596 | 0.0% |
| Biopharmx Corp | COM | 09072X101 | $502 | 1,342,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $500 | 8,560 | 0.0% |
| Cascadian Therapeutics IncCall | COM | 14740B901 | $447 | 103,800 | 0.0% |